Innovative Soft Capsules - Alginate Capsule Technology

Utilizing a novel patented process (alginate) this technology provides a unique seamless, enteric, vegetarian alternative to gelatin soft capsules in one unit process for pharmaceutical and nutraceutical applications.

Alginate capsules advantages:

  • Globally acceptable regulatory compliance with Vegetarian (gelatin-free)

  • Capsules easier to swallow:

  • Smaller Capsule: Seamless thinner capsule shell, allowing for capsules 30% smaller than traditional gelatin for a given fill volume

  • No Fish Burps: Naturally enteric providing superior gastro resistant and enteric release properties to film coated alternatives

  • Superior elegance - high shell transparency

  • Sugar and gluten free

Manufacture of capsules easier:

  • Favorable unit cost - process does not produce waste ribbon as seen in traditional rotary die processes and eliminates need/cost of enteric film coating maximizing production efficiency

  • Process designed to provide oxidation protection

  • QbD development philosophy

  • Patented product and process enables product life cycle enhancement.

  • IP Protected


  • Laboratory scale process enables:

  • Technology demonstrations

  • Formulation development support

  • Product concept assessment

  • Sample manufacture for in vitro and stability assessment

Proven GMP capability:

Small GMP batches for early in vivo testing


Related Applications


Dow’s excipients for drug abuse deterrence applications provide tamper resistant properties.


Dow offers solutions to protect APIs from environmental conditions and increase the stability of a drug’s long-term quality, efficacy and safety


Alginate-based impressions are attractive as orthodontic study models for a variety of reasons. These are fast setting at room temperature, easy to prepare, and very cost effective.


Dow’s excipients for the enteric coating of pharmaceutical tablets.


An enteric coating resists disintegration in the low pH of the stomach and is dissolved in the neutral pH environment of the intestine


Suspensions are pharmaceutically stable dispersions of an insoluble or sparingly-soluble drug in a liquid vehicle, usually an aqueous solution. They can be ready-to-use or reconstitutable, where the drug is mixed with other ingredients in the dry state and reconstituted with water at the time of dispensing to the patient.


Use of Avicel® DG dramatically increases tablet hardness, improves yields and provides good flow and a robust ribbon during the initial compaction phase


Dow’s excipients for controlled or modified release tablet and capsule formulations.


Dow’s excipients for the nasal administration of pharmaceuticals.


Chewable tablets as a dosage form are growing in popularity. Palatable chewable tablets offer convenience for customers, broaden the applicability of formulations to pediatric or geriatric markets, and increase patient compliance


Rheology modifier, dosage form, liquid dosage forms, semi-solid formulations, thickeners, topical applications, thickening agent, Dow, Dow Pharma Solutions, METHOCEL, WALOCEL


Dow’s portfolio of solubility enhancing excipients for drug compounds with low aqueous solubility.


Dow’s excipients for film tablet coatings are tough, printable, economical and highly consistent.


Dow’s excipients for taste masking applications in the oral drug delivery of tablets.


Topical formulations enable local delivery of a drug to a specific site of action without systemic exposure and may be creams, gels, or sprays.

Get Started

DuPont cares about your privacy. Your personal information (name, email, phone number and other contact data) will be stored in chosen customer systems primarily hosted in the United States. This information will be used by DuPont, its affiliates, partners, and selected third parties in other countries to provide you with the product or service information requested. To learn more, please visit By providing your personal information, you agree to the terms and conditions of this Privacy Statement.

/content/dupont/amer/us/en/nutrition-biosciences/references/contact-us.html /content/dupont/amer/us/en/nutrition-biosciences/references/corporate-contact-us.html /content/dupont/amer/us/en/nutrition-biosciences/references/subscribe.html